Paramount’s Sixth ‘Scary Movie’ Horror/Comedy Looks to Top Weekend Box Office Through June 7

Why It Matters

The strong opening underscores the commercial power of revived comedy‑horror franchises and signals that recognizable IP can still dominate a crowded summer slate, influencing studio release strategies and investor confidence.

Key Takeaways

• Scary Movie 6 projected $51.5 M opening, topping franchise record.
• Ticket price inflation adds $2 M advantage over 2003 benchmark.
• Amazon’s Masters of the Universe trails with $31.5 M projection.
• Indie film Backrooms drops to #3 with $26 M second‑weekend.
• Obsessions nets $25 M fourth‑weekend on $1 M budget.

Pulse Analysis

Paramount’s "Scary Movie" reboot demonstrates how legacy comedy‑horror brands can still command massive opening weekends. The $51.5 million projection not only surpasses the $49.7 million record set by the 2003 third installment, it does so in an era where average ticket prices have risen roughly 23 percent since the early 2000s. The return of Marlon and Shawn Wayans, coupled with director Michael Tiddes’ fresh take, provides a nostalgic hook that resonates with both original fans and a new generation of moviegoers, reinforcing the franchise’s market relevance.

The film’s projected lead also reshapes the early‑summer hierarchy. Amazon MGM Studios’ "Masters of the Universe" is slated for $31.5 million, while A24’s indie "Backrooms" falls to third place with a $26 million second‑weekend, highlighting the premium placed on recognizable IP versus original content. Meanwhile, low‑budget indie "Obsessions," made for roughly $1 million, is on track for a $25 million fourth‑weekend, illustrating that strong word‑of‑mouth can still generate sizable returns. Ancillary releases like "Star Wars: The Mandalorian and Grogu" and Lionsgate’s "Michael" add modest but steady revenue, underscoring a diversified box‑office ecosystem.

For studios, the numbers reinforce a strategic pivot toward franchise revitalizations and cross‑generational casting to mitigate risk in a competitive market. The inflation‑adjusted earnings suggest that ticket‑price growth can amplify headline figures, making high‑budget sequels appear even more lucrative. However, the success of micro‑budget titles like "Obsessions" reminds investors that cost‑effective storytelling remains a viable path to profit. As summer 2026 unfolds, the balance between blockbuster tentpoles and agile indie projects will likely dictate overall theatrical health.